deltatrials
Recruiting PHASE2 INTERVENTIONAL 1-arm NCT01803542

Stereotactic Radiotherapy (SBRT) of Lung Metastasis (SBRT Lung)

Lung Stereotactic Radiation Therapy for Patients With Non-small Cell Lung Cancer and Other Cancers

Sponsor: Princess Margaret Hospital, Canada

Conditions Metastasis From Other Cancers Non-small Cell Lung Cancer
Interventions Stereotactic Radiation
Updated 16 times since 2017 Last updated: Mar 3, 2026 Started: Mar 31, 2006 Primary completion: Sep 30, 2027 Completion: Sep 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01803542, this PHASE2 trial focuses on Metastasis From Other Cancers and Non-small Cell Lung Cancer and remains actively recruiting participants. Sponsored by Princess Margaret Hospital, Canada, it has been updated 16 times since 2006, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshot~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshot~Nov 2018 – ~Dec 2019 · 13 months · monthly snapshot~Dec 2019 – ~Sep 2020 · 9 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Nov 2021 · 2 months · monthly snapshot~Nov 2021 – ~Nov 2022 · 12 months · monthly snapshot~Nov 2022 – ~May 2023 · 6 months · monthly snapshot~May 2023 – ~Nov 2023 · 6 months · monthly snapshot~Nov 2023 – ~Jul 2024 · 8 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshot~Mar 2025 – ~Mar 2026 · 12 months · monthly snapshot~Mar 2026 – present · 5 months · monthly snapshot

Change History

16 versions recorded

  1. Mar 2026 — Present [monthly]

    Recruiting PHASE2

  2. Mar 2025 — Mar 2026 [monthly]

    Recruiting PHASE2

  3. Sep 2024 — Mar 2025 [monthly]

    Recruiting PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE2

  5. Nov 2023 — Jul 2024 [monthly]

    Recruiting PHASE2

▶ Show 11 earlier versions

  1. May 2023 — Nov 2023 [monthly]

    Recruiting PHASE2

  2. Nov 2022 — May 2023 [monthly]

    Recruiting PHASE2

  3. Nov 2021 — Nov 2022 [monthly]

    Recruiting PHASE2

  4. Sep 2021 — Nov 2021 [monthly]

    Recruiting PHASE2

  5. May 2021 — Sep 2021 [monthly]

    Recruiting PHASE2

  6. Jan 2021 — May 2021 [monthly]

    Recruiting PHASE2

  7. Sep 2020 — Jan 2021 [monthly]

    Recruiting PHASE2

  8. Dec 2019 — Sep 2020 [monthly]

    Recruiting PHASE2

  9. Nov 2018 — Dec 2019 [monthly]

    Recruiting PHASE2

  10. Jun 2018 — Nov 2018 [monthly]

    Recruiting PHASE2

  11. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

    First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Princess Margaret Hospital, Canada
  • University Health Network, Toronto
Data source: University Health Network, Toronto

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations